Uzbekistan Pharmaceuticals & Healthcare Report Q1 2014 - New Market Research Report
Our projections for the Uzbek pharmaceutical and healthcare markets going into 2014 are broadly bearish. The country continues to rank as the least attractive in the region in our RRR ratings matrix, and real GDP growth is set to decline. We note that there have been some positive developments in recent months, such as impetus to improve the healthcare sector, investment from state-run Uzpharmprom to develop domestic production and Chinese investment to supply some economic stability. However, it will be...
View full press release